Nanoencapsulation of MDM2 inhibitor RG7388 and class-I HDAC inhibitor entinostat enhances their therapeutic potential through synergistic antitumor effects and reduction of systemic toxicity

Anas Abed, Michelle K Greene, Alhareth A Alsa'd, Andrea Lees, Andrew Hindley, Daniel B Longley, Simon S McDade, Christopher J Scott*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)
31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Nanoencapsulation of MDM2 inhibitor RG7388 and class-I HDAC inhibitor entinostat enhances their therapeutic potential through synergistic antitumor effects and reduction of systemic toxicity'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science